Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013

Slides:



Advertisements
Similar presentations
Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Advertisements

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Improving diagnosis TB laboratory strengthening.
Tuberculosis in India: A Critical Analysis Lynette Menezes, MSW.
TB and HIV: Tightly Linked… and Why We Should Care.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 Patent medicines vendors a resource.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Monitoring & Evaluation of RNTCP
Revised National Tuberculosis Control Programme (RNTCP)
World Health Organization
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Role of Pharmacist in Malaria Control
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Monitoring and Evaluation Module 12 – March 2010.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Sri Lankan Perspective Dr Nihal Abeysinghe M.B.,B.S., MSc, M.D. (Community Medicine) Chief Epidemiologist Ministry of Health, Nutrition & Welfare Place.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Health care utilization patterns and economic consequences of TB Dr. K. Zaman ICDDR,B National TB Conference 2007, NATAB.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Roundtable. Detection and treatment of TB Andrew Black.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Strengthening TB and HIV&AIDS Responses in East Central Uganda Strengthening Laboratory TB diagnostic capacity of peripheral laboratories in East Central.
Monitoring and Evaluation: A Review of Terms
Monitoring and Evaluation Frameworks
TB- HIV Collaborative activities in Romania- may 2006 status
Philippe Glaziou Geneva, 12 October 2009
Free State TB Information
Zaw Win, Tin Aung, Sun Tun Population Services International/ Myanmar
TB Control in PHC network and Partners Coordination in Cambodia
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
Lessons learned from Hospital DOTS Linkage (HDL) in Yogyakarta Indonesia Jan Voskens MPH, KNCV GTI/UAB.
TUBERCULOSIS SURVEILLENCE KENYA
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Implementing a TB-Control Program in Prisons: The Basics
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Indian Scenario HIV Situation TB Situation
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
TB epidemiological situation in Kyrgyzstan
DOTS EXPANSION AND BEYOND DOTS World Health Organization
From TB control to integrated respiratory disease control
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program in Vietnam
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Issues on the current information system
The STOP TB Strategy – 2009 VISION: A TB-free world
Monitoring and Evaluation: A Review of Terms
Abstract Problem Statement: Armenia received anti-TB drugs from the Global Drug Facility to treat patients in the civil sector in January 2003, whereas.
Presentation transcript:

Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013

Three fundamental issues The health problem Prevalence, incidence, ”disease burden” The service delivery Facilities, strategies/programs, activities The resources Man-power, skills, supplies, support ->Outcome / impact

Conflict of interest? Control: Global/national/local/personal ”Bottom-up strategy” (democratic) Rights: Needs/justice/legal/private Data quality, data safety, integration Efficiency: Needs – resources Analyses and research Safety: Epidemics/hazards/life-style Surveillance

Example: Tuberculosis control Objectives Reduce mortality Detect and treat cases (morbidity) Cure sputum positive cases Reduce transmission DOTS : 1. political commitment 2. diagnosis through microscopy 3. drugs supply 4. observed therapy 5. recording and reporting

Tuberculosis control “Information culture” Central management unit (in MoH) National standard formats TBMUs -> Province -> CU -> MoH Standards used as basis for supervision Emphasis on treatment outcome Often functions in isolation from PHC

Tuberculosis control What kind of data? Classification New pulm. sm+ Pulm. sm – Extra pulm. Transfer in Retreatment Relapse Treatment outcome Cured Treatm. Completed Dead Transferred out Chronic (“failure”) Lost to follow-up

Tuberculosis control What sources of data? Laboratory book TB suspects, results of 2 smears, follow-ups Treatment card Demographic data, classification, treatment, weight, regularity, lab.res. Registration book Classification, treatment outcome, comments Supervision reports Problems, solutions, data quality

Tuberculosis control Flow / loss of information Symptomatics Laboratory TBM Province National International (WHO) PHC Hospital serv. ”Symptomatics” Laboratory TBMU PHC Hospitals Non-TB / TB Private / public DOTS centr.

Tuberculosis control What we can learn from the laboratory book External quality control Work load and in service training Suspect/positive ratio Quality of diagnostic microscopy routine Quality of follow-up Transfer to treatment cards

Tuberculosis control What we can learn from the treatment cards Accuracy of diagnosis/classification Weight gain/loss Address* (and social background) Treatment regularity Regimen and drug reactions Treatment outcome Transfer to registration book

Tuberculosis control What we can learn from the registration book Incidence* and classification / PHC unit Treatment outcome / PHC unit Childhood TB (active transmission) Mortality (HIV etc) Extra pulmonary TB (HIV, M.bovis etc) Gender balance Transfer to CU/MoH reports

Tuberculosis control The problem of coverage WHO target: Detect 70% of estimated new cases What is the basis for the estimate? The private sector? Double reporting? Alternatives: 1. Geographical and social accessibility (GIS/season/social strata/etc) 2. Diagnostic delay

Tuberculosis control Integration into PHC In principle, but often not in reality Resources (transport, pharmacy, statistician, laboratory, supervision, data management) Culture (treatment outcome, data quality, district management, health rights) Power (supplies, supervision, staffing) Satisfaction (outcome data)

Challenge / solution Central control Quality of data Efficiency Reporting Local problems Success ”The big picture” Peripheral analyses Used by ”producers” Training Supplies etc Documented needs Treatment outcome Local interactions